Becton, Dickinson and Company and C. R. Bard, Inc. have agreed to divest two medical device product lines to settle Federal Trade Commission charges that Becton, Dickinson’s proposed $24 billion acquisition of Bard would negatively impact competition in those markets. Both companies supply a range of medical devices to health care organizations, healthcare workers, and […]